Illumina Debuts New BeadChips to Meet 'Continued Interest' from GWAS, Agbio Markets

The San Diego firm views both the GWAS and agbio market segments as opportunities for its arrays, and plans additional product launches this year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.